At a glance
- Originator Roche
- Class Antihypertensives; Organic nitrates; Vasodilators
- Mechanism of Action Guanylate cyclase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Ischaemic heart disorders
Most Recent Events
- 14 Feb 1995 Preclinical development for Heart failure in Germany (Unknown route)
- 14 Feb 1995 Preclinical development for Ischaemic heart disorders in Germany (Unknown route)